ホームページへ
4.6/5
TrustPilot

イスタンブールで最高のCAR-T細胞療法医師 - トップ9名の医師

トルコのトップCAR-T細胞療法医師と価格を比較。こちらで最適なマッチングを見つけてください

トルコの3名のトップCAR-T細胞療法専門家から見積もりを取得

ご要望と予算に基づいて最適な医師を厳選いたします

トップ医師

9

トルコ

レビュー

14000+

実際の患者より

医師サービスで最良価格の国を選択

トップ各国のCAR-T細胞療法価格を比較

国をタップしてトップ医師と価格を表示

Israel
Ukraine
Turkey
Poland
Mexico
Thailand
$72,000 - $112,800
$150,000 - $250,000
$150,000 - $225,000
$150,000 - $250,000
$250,000 - $400,000
$250,000 - $350,000
$0
$64,000
$128,000
$192,000
$256,000
$320,000
$384,000

個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし

最初に表示:

Ceyhun Bozkurt

  • 36年の経験
  • 所在地: トルコ, イスタンブール
  • Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

    Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

  • 続きを読む
診察
お問い合わせください

Serdar Bedii Omay

  • 4 良い 1 レビュー
  • 36年の経験
  • 所在地: トルコ, イスタンブール
  • クリニック:
    4.1
    Emsey Hospital
  • Serdar Bedii Omay教授は、血液学および骨髄移植の分野において65本以上の科学論文を発表しています。三重大学医学部にて分子血液学の研鑽を積みました。

    • 数十年にわたる豊富な経験を持つ血液学教授
    • 65本以上の論文および112本の学会発表論文を執筆
    • 三重大学医学部にて分子血液学を専門的に修得
  • 続きを読む
診察
お問い合わせください

Adem Topaloglu

  • 15年の経験
  • 所在地: トルコ, イスタンブール
  • クリニック:ERDEM HOSPITAL
  • Dr. Adem Topaloglu is a general surgeon with expertise in laparoscopic oncology. He focuses on colon and rectal cancers. He graduated from Karadeniz Technical University Faculty of Medicine in 1998. He completed his general surgery training at Eskişehir Osmangazi University in 2009.

    Dr. Topaloglu performs advanced minimally invasive surgeries. His procedures include laparoscopic gastric, colon, and rectal cancer surgeries, as well as anti-reflux surgery, hernia repairs, appendectomy, and cholecystectomy. He is also experienced in endocrine and gastroenterological surgeries. In addition, he performs bariatric procedures such as gastric sleeve, bypass, and balloon interventions.

    Dr. Topaloglu holds certifications in obesity, hiatal, and inguinal hernia surgeries. He is skilled in gastroscopy and colonoscopy. His expertise helps improve patient outcomes and surgical success rates.

  • 続きを読む
診察
お問い合わせください

Rafet Eren

  • 19年の経験
  • 所在地: トルコ, イスタンブール
  • クリニック:Biruni University Hospital
  • Education

    • Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
    • MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
    • PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
    • Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

    Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

    Scientific Memberships

    • Turkish Hematology Association
    • Hematology Specialty Society
    • Turkish Internal Medicine Specialty Society
    • European Society of Hematology
    •  

    Awards 

    • Young Researcher Award (42nd National Hematology Congress), 2016
    • Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
    • Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016
  • 続きを読む
診察
お問い合わせください

Hilmi Apak

  • 26年の経験
  • 所在地: トルコ, イスタンブール
  • クリニック:Biruni University Hospital
  • Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

    He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

  • 続きを読む
診察
お問い合わせください

Birol Baytan

  • 34年の経験
  • 所在地: トルコ, イスタンブール
  • クリニック:
    4.1
    Emsey Hospital
  • 経歴と教育

    ベイタン教授は1992年にアンカラ大学医学部を卒業し、ウルドゥグ大学医学部児童疾患学科で医学の専門家となりました。2002年には、同じ機関で小児血液学の助教授として働きました。

    彼はまた、小児がん、白血病(リンパ腫)、小児出血性疾患の治療、血管閉塞、貧血治療、鉄欠乏症およびビタミン欠乏症の治療などの診断と治療に特化しています。

     

    学術経験

    ベイタン教授は、国際査読付きジャーナルに発表された15の論文、国際科学会議で発表および出版された9つの全文、地方/外国語で書かれた3つの書籍/書籍の章、地方査読付きジャーナルに公開された8つの論文を有しています。

     

     

  • 続きを読む
診察
お問い合わせください

Itir Sirinoglu Temiz

  • 36年の経験
  • 所在地: トルコ, イスタンブール
  • クリニック:
    4.9
    Liv Hospital Vadistanbul
  • Dr. Itir Sirinoglu Temiz is a Professor of Hematology. She specializes in lymphoma, acute and chronic leukemias, multiple myeloma, thrombocytopenias, thrombosis, anemia, and bone marrow failure. She graduated with honors from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her hematology training at Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital.

    Dr. Sirinoglu Temiz has held key academic and administrative positions. She served as Head of Internal Medicine at IAU Faculty of Medicine. She was also Education and Administrative Manager at SBÜ Bakırköy Dr. Sadi Konuk EAH Hematology Clinic. She has broad experience in adult hematology, stem cell transplantation, and therapeutic apheresis. She currently practices at Liv Hospital.

  • 続きを読む
診察
お問い合わせください

Ali Hakan Kaya

  • 20年の経験
  • 所在地: トルコ, イスタンブール
  • クリニック:Biruni University Hospital
  • Education

    • Faculty of Medicine - Cerrahpaşa Faculty of Medicine 1999-2005
    • Internal Medicine Residency - Istanbul Haseki Training and Research Hospital 2006-2010
    • Hematology Subspecialist Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital - Hematology and Stem Cell Transplant Clinic 2013-2017
    • Associate ProfessorIstanbul Ümraniye Training and Research Hospital 2019
    •  

    Experience

    • Assistant Doctor Istanbul Haseki Training and Research Hospital - Internal Medicine Clinic 2006-2010
    • Internal Medicine Specialist Istanbul Esenyurt State Hospital 2010-2012
    • Internal Medicine Specialist-Military service Samsun Military Hospital 2012-2013
    • Subspecialty Training Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital - Hematology and Stem Cell Transplant Clinic 2013-2017
    • Hematology Subspecialist Ankara Gülhane Training and Research Hospital, Hematology and Stem Cell Transplant Clinic 2017-2018
    • Hematology Subspecialist Istanbul Ümraniye Training and Research Hospital/Hematology 2018-2019
    • Associate Professor Istanbul Ümraniye Training and Research Hospital/Hematology 2019-2021
    • Associate Professor Maltepe University Faculty of Medicine / Hematology 2021-2024
    • Associate Professor Istanbul VM Medical Park Pendik Hospital / Hematology and Stem Cell Transplant Clinic 2022-2024
    •  

    Scientific Memberships

    • Turkish Medical Association
    • Turkish Apheresis Society
    • Hematologic Oncology Society
    • Blood and Bone Marrow Transplant Association
    • Hematologic Immunology Society
    •  

    Awards

    •  
    • Hematologic Oncology Society, 2015 - Second Prize for Paper
    • Hematologic Oncology Society, 2016 - Second Prize for Paper
    • Turkish Apheresis Association, 2016 - Paper Third Prize,
    • Hematologic Immunology Association, 2016 - Second Prize for Paper
    • Hematologic Oncology Society, 2016 - Second Prize for Paper
    • Blood and Bone Marrow Transplantation Association, 2017 - First Prize for Paper
       
  • 続きを読む
診察
お問い合わせください

海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。

ヤン・マツィイフスキー

医療コーディネーターチーム責任者

4300+件以上の患者の旅をガイド

Bookimedで3

Turkeyの278名の患者が今月当社を通じて医師を見つけました

完璧な医師マッチングを取得する方法

1

2分のクイズ

目標、予算、スケジュールをお聞かせください

2

人間のマッチング + AI

アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します

3

オプション準備完了

価格、パッケージ、日程を比較。コーディネーターとチャット

選択肢に迷っていますか?

専属の Bookimedコーディネーターがお客様のニーズに合わせた完璧な外科医を見つけるお手伝いをします

  • すべての段階で24時間365日サポート
  • 医師とのマッチングサポートとクリニックとの全てのコミュニケーションを処理
  • 旅行、宿泊、送迎を調整します

治療をガイド

医療訓練を受けた専属コーディネーター

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

適切な医師とクリニックの選び方:内部者のヒント

医師やクリニックを選ぶ際は、これらの重要なポイントを覚えておいてください:
資格を確認
ISAPS、JCI、または関連医学会などの機関からの認証を確認してください
成功率を確認
お客様の特定治療に豊富な経験と実績のある医師をお選びください
患者レビューを読む
実際の患者様のBookimedレビューをご覧になり、体験について学んでください
効果的なコミュニケーションの確保
円滑な治療のため言語サポートを提供するクリニックを選んでください。
サービスについて質問
隠れた費用を避けるため、価格に宿泊、現地送迎、アフターケアなどのサービスが含まれているかご確認ください

Bookimed洞察:トルコのトップCAR-T細胞療法専門家(2026)

BookimedはトルコのCAR-T細胞療法リクエスト29件を調整し、9名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています
順位医師経験適合する方特色クリニックと所在地診察
#136年の経験CAR T細胞療法分子血液学を専門とし、最先端治療の研究に従事。血液学および骨髄移植に関する論文を65本以上発表。エーゲ大学およびカラデニズ工科大学の教授。
トルコ
から $110

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

How do doctors in Turkey handle the logistics of CAR T-cell therapy?

Doctors in Turkey manage CAR T-cell therapy through a synchronized pipeline involving cell collection, specialized transport, and inpatient monitoring. Leading hematologists integrate international logistics with Joint Commission International (JCI) accredited facilities. They use the vein-to-vein model to maintain cell viability during engineering and re-infusion processes.

  • Cell collection: Specialists perform apheresis to harvest T-cells using temperature-controlled cryopreservation techniques.
  • Manufacturing logistics: Teams coordinate with domestic labs or international hubs to engineer patient cells.
  • Bridging therapy: Hematologists design temporary treatment regimens to stabilize the patient during the manufacturing period.
  • Post-infusion care: Patients stay in isolated bone marrow units for 14+ days to monitor progress.

Bookimed Expert Insight: Turkish specialists provide a significant clinical advantage through their extensive training at top global institutions. Dr. Osman Ilhan at Private Koru Ankara Hospital trained at MD Anderson Cancer Center. Dr. Ceyhun Bozkurt of Medical Park studied at Harvard and Cincinnati Children's. This international background allows them to manage complex cross-border cell manufacturing protocols efficiently.

Patient Consensus: Patients describe the process as a multi-step puzzle that requires staying near the hospital for several weeks. They note it is helpful to have the medical team handle shipping and customs paperwork. Many emphasize that clear communication about lab timelines and bed availability helps reduce stress during the wait.

Which medical specialties do CAR T-cell therapy doctors in Turkey hold?

CAR T-cell therapy doctors in Turkey primarily hold dual specializations in hematology and medical oncology. These experts focus on treating complex blood cancers through advanced cellular modification and bone marrow transplantation. Many specialists are internationally trained in molecular hematology and stem cell research.

  • Adult hematology: Physicians like Dr. Serdar Bedii Omay specialize in molecular blood disorders and transplantation.
  • Pediatric hematology-oncology: Experts like Dr. Ceyhun Bozkurt treat childhood leukemias using specialized cellular protocols.
  • Medical oncology: Specialists manage solid tumors and lymphomas while overseen by bone marrow transplant directors.
  • Stem cell transplantation: Doctors often lead JCI-accredited units with training from institutions like MD Anderson.

Bookimed Expert Insight: Leading Turkish specialists often hold academic leadership roles and possess extensive research backgrounds. For example, Dr. Osman Ilhan helped perform the first bone marrow transplant in Turkey. This indicates that patients receive care from pioneers who founded the country's cellular therapy associations and hold patents in hematology innovation.

Patient Consensus: Patients note that their care is guided by hematologist-oncologists while specialized transplant teams handle cell collection and infusion. Many highlight the importance of choosing centers with 24/7 inpatient monitoring to manage potential inflammatory reactions safely.

Do Turkish CAR T-cell doctors have international training or certifications?

Leading Turkish CAR T-cell therapy doctors maintain extensive international training and holds credentials from elite global medical institutions. These senior hematologists frequently complete fellowships and research tenures at centers like MD Anderson Cancer Center and Harvard University's Dana-Farber Cancer Institute.

  • Global training: Specialists like Dr. Osman Ilhan trained at MD Anderson and University of Genoa.
  • Elite affiliations: Many doctors hold active memberships in the European Society for Blood and Marrow Transplantation.
  • Academic leadership: Dr. Ceyhun Bozkurt conducted specialized research at Cincinnati Children's Hospital in the USA.
  • International research: Prof. Serdar Bedii Omay trained at Japan Mie Medical School and published 65+ articles.

Bookimed Expert Insight: Data shows that top Turkish hematologists often hold leadership roles in global regulatory bodies. For example, Dr. Osman Ilhan served as President of the Turkish Hematology Association and received a Platinum CME certificate from the European Hematology Association. This indicates that Turkish specialists are not just followers of global protocols but active contributors to international cellular therapy standards.

Patient Consensus: Patients note that while international degrees are impressive, the team's ability to manage treatment side effects is what truly matters. They emphasize checking if the hospital has a dedicated ICU and pharmacy support for complex cell therapies. Many feel more confident when the medical team has managed numerous cases and follows recognized CAR T pathways.

Who are the leading doctors offering adult CAR T-cell therapy in Turkey?

Leading specialists in Turkey for adult CAR T-cell therapy hold extensive backgrounds in hematology and stem cell transplantation. These experts typically practice at JCI-accredited facilities in Istanbul and Ankara. They possess specialized training from top international institutions and lead dedicated cellular immunotherapy programs for blood cancers.

  • Dr. Osman Ilhan: Pioneer who performed Turkey's first stem cell transplant with MD Anderson training.
  • Dr. Serdar Bedii Omay: Specialist in molecular hematology with doctoral training from Mie Medical School in Japan.
  • Dr. Bulent Eser: Member of the European Group for Blood and Marrow Transplantation at Medical Park.
  • Dr. Sarah Sirinoglu Temiz: Expert in therapeutic apheresis who previously managed specialized stem cell transplantation units.

Bookimed Expert Insight: Data shows that top hematologists in Turkey often hold cross-continental credentials. Dr. Serdar Bedii Omay and Dr. Osman Ilhan possess specific training from Japan, Italy, and the USA. This international exposure is vital for CAR T-cell therapy. It ensures they stay updated on global protocols for managing complex side effects like cytokine release syndrome.

Patient Consensus: Patients emphasize selecting centers that manage the entire cellular manufacturing process on-site. Realizing that the team has experience with specific post-infusion side effects like confusion or fever provides peace of mind. Many note that having coordinators handle the long six-week monitoring period makes the complex logistics manageable.

Who are the top pediatric CAR T-cell therapy doctors in Turkey?

Top pediatric CAR T-cell therapy doctors in Turkey include Dr. Ceyhun Bozkurt and Dr. Hilmi Apak. These experts lead dedicated units with training from Cincinnati Children's and Harvard's Dana-Farber. They specialize in treating childhood leukemia and lymphoma using advanced cellular protocols and JCI-accredited laboratory infrastructure.

  • Dr. Ceyhun Bozkurt: Director at Medical Park Bahcelievler with fellowship training at Cincinnati Children's Hospital.
  • Dr. Hilmi Apak: Heads the pediatric division at Biruni University with over 75 international publications.
  • Dr. Birol Baytan: Specialist at Emsey Hospital with 20+ years of experience in childhood blood disorders.
  • Center expertise: Medical Park and Biruni University provide specialized intensive care for managing pediatric complications.

Bookimed Expert Insight: Data shows that top Turkish specialists like Dr. Osman Ilhan and Dr. Ceyhun Bozkurt are not just clinicians but pioneers who established the nation's stem cell banks. Dr. Ilhan performed Turkey's first bone marrow transplant and holds over 300 PubMed-indexed publications. This academic leadership ensures that pediatric protocols in Istanbul follow the latest international cellular therapy guidelines.

Patient Consensus: Parents emphasize that the hospital's intensive care protocols are as important as the doctor's name. They often notice that coordination between the stem cell unit and ICU teams is vital for managing side effects. Families feel more at ease when physicians provide clear timelines for the infusion and recovery process.

How much hands-on procedural experience do Turkish CAR T-cell doctors typically have?

Turkish CAR T-cell doctors possess extensive hands-on experience by leveraging decades of bone marrow transplantation expertise. Leading specialists often have over 30 to 45 years of clinical practice. They have performed over 900 cellular procedures, adapting these skills to manage cell harvesting and immunotherapy complex reactions.

  • Transplant-led foundation: Experts like Dr. Osman Ilhan pioneered Turkey's first bone marrow stem-cell transplants.
  • International fellowship training: Surgeons trained at prestigious centers like MD Anderson and Harvard University.
  • Dual-specialty mastery: Practitioners often hold dual certifications in internal medicine and hematology or oncology.
  • High procedural volume: Senior clinicians at Emsey Hospital have 40+ years of progressive academic experience.

Bookimed Expert Insight: Data suggests a pattern where Turkey's top experts are not just clinicians but founders of national cellular therapy societies. For instance, Dr. Osman Ilhan at Private Koru Ankara Hospital holds four medical patents. This academic leadership indicates that patients receive care from doctors who literally wrote the national protocols for cell handling and apheresis.

Patient Consensus: Patients note that their confidence grew when they saw the entire team working together. They felt safer knowing the clinics had 24/7 ICU support and dedicated coordinators to manage side effects like cytokine release. Most patients were relieved to find specialists who were used to high-risk inpatient care.

How do Turkish doctors manage the in-house production and timing of CAR T-cells?

Turkish doctors manage CAR T-cell production through point-of-care manufacturing at Good Manufacturing Practice (GMP) certified facilities. This decentralized approach eliminates overseas shipping and optimizes the vein-to-vein timeline. Highly qualified hematologists use chemical inhibitors like BX-795 to accelerate gene delivery and cell expansion processes.

  • Technical acceleration: Doctors use the BX-795 inhibitor to block antiviral signaling in T-cells.
  • Optimized timing: Local production reduces the manufacturing window to just 9 to 12 days.
  • Fresh infusion: In-house manufacturing avoids cryopreservation to maintain maximum cellular potency and survival.
  • Adaptive protocols: Clinicians coordinate bridging therapy on-site to stabilize the patient during cell growth.

Bookimed Expert Insight: Data shows that top Turkish specialists like Dr. Osman Ilhan at Private Koru Ankara Hospital and Dr. Serdar Bedii Omay at Emsey Hospital integrate molecular hematology with extensive apheresis experience. This dual expertise is vital because it allows centers to manage both the industrial manufacturing of cells and the immediate clinical needs of the patient under one roof.

Patient Consensus: Patients note that a smooth pipeline between cell collection and infusion is essential to reduce anxiety. They appreciate when a center provides a clear turnaround time before the process starts. Many were surprised that the process feels like an industrial sequence where scheduling discipline is just as important as medical care.

Can international patients easily communicate with CAR T-cell doctors in Turkey?

International patients communicate effectively with CAR T-cell doctors in Turkey through structured support systems and multilingual medical staff. Leading hematologists often hold international fellowships from institutions like Harvard or MD Anderson. Hospitals provide dedicated coordinators and native-speaking interpreters to manage every step of the complex oncology journey.

  • Specialized coordinators: Dedicated staff manage logistics from initial scan reviews to post-infusion follow-up.
  • Multilingual expertise: Doctors like Dr. Rafet Eren are fluent in English for direct communication.
  • International training: Many professors completed training in the USA, Japan, or Europe.
  • Written documentation: Medical teams provide translated instructions for after-care and medication management.

Bookimed Expert Insight: Data shows that Turkey's cellular therapy leaders, such as Dr. Osman Ilhan and Dr. Ceyhun Bozkurt, often lead dedicated stem cell units. These experts frequently serve as presidents of national hematology associations. This dual role means they oversee both the clinical treatment and the specialized lab teams. Patients benefit from this integrated oversight during the apheresis and infusion stages.

Patient Consensus: Patients note that having a single translator throughout the multi-week hospital stay makes the process much easier. They emphasize the value of using WhatsApp for quick updates between physician rounds. Many find that receiving written summaries of side effects helps them feel more prepared for recovery.